Department of Head and Neck Surgery-Institute of Otorhinolaryngology, Catholic University School of Medicine and Surgery, Rome, Italy.
Department of Diagnostic and Laboratory Medicine-Institute of Biochemistry and Clinical Biochemistry, Catholic University School of Medicine and Surgery, Rome, Italy.
Int Forum Allergy Rhinol. 2015 Jun;5(6):557-62. doi: 10.1002/alr.21519. Epub 2015 Mar 26.
The aim of the present study was to measure levels of granulocyte-macrophage colony-stimulating factor (GM-CSF) in nasal lavage of patients affected by chronic eosinophilic sinonasal inflammation to clarify the relationship with eosinophilic tissue infiltration and clinical features.
Between November 2012 and June 2013, we selected 70 patients with chronic eosinophilic inflammation (average age 41.8 years) who were classified into the following groups: persistent allergic rhinitis (group 1), noninfectious non-allergic rhinitis with eosinophilia syndrome (group 2) and chronic rhinosinusitis with polyps (group 3). Finally, we enrolled 20 healthy subjects as controls (group 4). All patients underwent symptoms score questionnaire based on a visual analogue scale, nasal endoscopy and/or computed tomography (CT) scan, and allergy testing. Nasal cytology by scraping of the mucosa and GM-CSF assays in nasal lavage were performed in all subjects.
Detectable levels of GM-CSF were found in 34 of 70 (48.57%) patients, with an average concentration of 2.67 ± 0.8 pg/mL, whereas in controls only 1 of 20 individuals showed detectable GM-CSF levels. Eosinophil infiltration was significantly higher in patients with detectable GM-CSF compared to those with undetectable levels (49.4% vs 39.2%, respectively; p < 0.05). Furthermore, significant weakly-moderate correlation was found between GM-CSF levels and percentage of eosinophil infiltration in tissue (p < 0.05). Correlation between symptom scores and GM-CSF levels was significant only in group 2, which showed higher average concentrations of GM-CSF compared to groups 1 and 3 (2.9 pg/mL vs 1.6 pg/mL and 1.8 pg/mL, respectively; p < 0.05).
Our data confirm that GM-CSF is more frequently detectable in nasal lavages of patients affected by chronic sinonasal eosinophilic inflammation than in controls. Statistical analyses revealed a significant weakly-moderate correlation between GM-CSF levels in nasal lavage of all patients and percentage of eosinophil infiltration of nasal mucosa.
本研究旨在测量慢性嗜酸性鼻-鼻窦炎患者鼻灌洗液中粒细胞-巨噬细胞集落刺激因子(GM-CSF)的水平,以明确其与嗜酸性组织浸润和临床特征的关系。
2012 年 11 月至 2013 年 6 月,我们选择了 70 例慢性嗜酸性炎症患者(平均年龄 41.8 岁),将其分为以下几组:持续性变应性鼻炎(第 1 组)、非感染性非变应性嗜酸性鼻炎伴嗜酸性粒细胞增多综合征(第 2 组)和慢性鼻-鼻窦炎伴息肉(第 3 组)。最后,我们招募了 20 例健康受试者作为对照组(第 4 组)。所有患者均接受症状评分问卷调查(基于视觉模拟量表)、鼻内镜检查和/或计算机断层扫描(CT)检查,以及过敏测试。所有受试者均进行鼻黏膜刮取细胞学检查和鼻灌洗液 GM-CSF 检测。
在 70 例患者中,有 34 例(48.57%)可检测到 GM-CSF,平均浓度为 2.67±0.8 pg/mL,而在对照组中,仅有 1 例可检测到 GM-CSF。与未检测到 GM-CSF 的患者相比,可检测到 GM-CSF 的患者嗜酸性粒细胞浸润显著更高(分别为 49.4%和 39.2%;p<0.05)。此外,GM-CSF 水平与组织中嗜酸性粒细胞浸润百分比之间存在显著的弱-中度相关性(p<0.05)。仅在第 2 组中,症状评分与 GM-CSF 水平之间存在显著相关性,与第 1 组和第 3 组相比,第 2 组 GM-CSF 的平均浓度更高(分别为 2.9 pg/mL、1.6 pg/mL 和 1.8 pg/mL;p<0.05)。
我们的数据证实,GM-CSF 在慢性鼻-鼻窦嗜酸性炎症患者的鼻灌洗液中比在对照组中更常被检测到。统计分析显示,所有患者鼻灌洗液中 GM-CSF 水平与鼻黏膜嗜酸性粒细胞浸润百分比之间存在显著的弱-中度相关性。